Randomized controlled trial on effectiveness of ultrasonography in breast cancer screening(Japan Strategic Anti-Cancer Randomized Trial)

Conditions

Breast Cancer

Narumi Harada‐Shoji, Akihiko Suzuki, Takanori Ishida, Yingfang Zheng, Yoko Narikawa-Shiono et al. (8 authors)

JAMA Network Open2021-08-1898 citations

10.1001/jamanetworkopen.2021.21505

Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial.

Ohuchi N, Suzuki A, Sobue T, Kawai M, Yamamoto S, Zheng YF, Shiono YN, Saito H, Kuriyama S, Tohno E, Endo T, Fukao A, Tsuji I, Yamaguchi T, Ohashi Y, Fukuda M, Ishida T, J-START investigator groups.

2015-11-05340 citations

10.1016/s0140-6736(15)00774-6

Participants' understanding of a randomized controlled trial (RCT) through informed consent procedures in the RCT for breast cancer screening, J-START.

Shiono YN, Zheng YF, Kikuya M, Kawai M, Ishida T, Kuriyama S, Ohuchi N.

2014-09-2510 citations

10.1186/1745-6215-15-375

Interventions

Ultrasonography added to mammography Mammography

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Women aged 40 to 49 years when registered. 2. Women signed the informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Women with history of breast cancer. 2. Women with history of malignant disease other than breast cancer within 5 years. 3. Women in severe condition, who are not expected to live for 5 years.

Design outcomes

Primary

Measure	Time frame
Sensitivity, specificity and detection rate of breast cancer	—

Secondary

Measure	Time frame
Accumulated incidence rate of advanced breast cancer	—

Countries

Japan

Contacts

Public ContactYOKO NARIKAWA

TOHOKU UNIVERSITY J-START research unit

narikawayoko@gmail.com022-272-3011

Outcome results

None listed